Tertatolol
From Wikipedia, the free encyclopedia
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
(±)-1-(tert-Butylamino)-3-(3,4-dihydro-2H-thiochromen-8-yloxy)propan-2-ol
|
|
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Legal status |
|
| Routes of administration |
Oral |
| Identifiers | |
| CAS Number | 34784-64-0  |
| ATC code | C07AA16 |
| PubChem | CID 36920 |
| IUPHAR/BPS | 571 |
| ChemSpider | 33875  |
| UNII | 9ZO341YQXP |
| KEGG | D07182 |
| ChEMBL | CHEMBL434200 |
| Chemical data | |
| Formula | C16H25NO2S |
| Molar mass | 295.44 g/mol |
|
|
|
|
| (what is this?) (verify) |
Tertatolol (Artex, Artexal, Prenalex) is a medication in the class of beta blockers, used in the treatment of high blood pressure. It was discovered by the French pharmaceutical company Servier and is marketed in Europe.[1]
Tertatolol has also been shown to act as a 5-HT1A receptor antagonist, similarly to pindolol.[2][3]
See also[edit]
References[edit]
- ^ Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. ISBN 3-88763-075-0.
- ^ Jolas T, Haj-Dahmane S, Lanfumey L, et al. (May 1993). "(-)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain". Naunyn-Schmiedeberg's Archives of Pharmacology 347 (5): 453–63. doi:10.1007/bf00166735. PMID 7686633.
- ^ Soudijn, W.; Olivier, Berend; Wijngaarden, I. van (1997). Serotonin receptors and their ligands. Amsterdam: Elsevier. ISBN 0-444-82041-8.
|
 |
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
